ASN-007

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameASN-007
Drug Alias NameASN-007ASN-0007ERAS-007ASN 007A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionExtracellular-signal-regulated kinase1 inhibitorsExtracellular-signal-regulated kinase 2 inhibitors
TargetsExtracellular-signal-regulated kinase1Extracellular-signal-regulated kinase 2
Therapy Area/IndicationsSolid tumoursNeoplasm MetastasisCarcinoma, Non-Small-Cell Lung +[10] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAsana Biosciences Llc
China Registration ClassN/A

Develop Information

Active CompaniesErasca Inc
Inactive CompaniesAsana Biosciences Llc
Active IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungColorectal Neoplasms +[4] 
Inactive IndicationsNeoplasm MetastasisLung NeoplasmsPancreatic Neoplasms +[6] 

Other Information

ATC CodeN/A
Related LinksN/A